Want to join the conversation?
$XOM's chemical earnings for 2Q16 declined by $29MM to $1.2Bil from 2Q15. Margins increased earnings by $150MM. Volume and mix effects increased earnings by $70MM. All other items decreased earnings by $250MM, due to the absence of asset management gains in the U.S. partly offset by lower expenses.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?